Statement of Changes in Beneficial Ownership (Form 4)
-2d
Management Change/Compensation (Form 8-K)
-2d
Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones
1/13
-44d
Management Change/Compensation Form 8 K
-44d
-44d
-45d
-2m
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
-2m
Statement of Changes in Beneficial Ownership - Form 4
-2m